Drugs / Carboxyprimaquine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05938608 | Mar 2024 → Mar 2025 | — | University of Oxford | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carboxyprimaquine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05938608 ↗ |
| Route | Intravenous | “Carboxyprimaquine 7.93 mg base in normal saline 500 mL infused over 30 minutes intravenously” NCT05938608 ↗ |